Member access

4-Traders Homepage  >  Shares  >  Xetra (Allemagne)  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

 (BAYN)
93
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra (Allemagne)
05/14/2013 05/15/2013 05/16/2013 05/17/2013 05/20/2013 Date
84.52(c) 85.03(c) 84.8(c) 83.79(c) 84.12 Last
1 462 619 1 822 995 1 716 374 4 501 891 1 002 671 Volume
+0.92% +0.60% -0.27% -1.19% +0.39% Change
More quotes
Company
Bayer is one of the world's leaders in designing, producing, and marketing pharmaceutical products and high-performance materials. Sales (not including sold divisions) are distributed by product family as follows: - healthcare products (46,8%): pharmaceutical products (58% of sales; intended for... 
Read more
Sector
Pharmaceuticals - Diversified
Calendar
05/20 | 02:30pmPresentation
Surperformance© rating of Bayer AG
Trading Rating : Investor Rating :
More about the company
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Financials (€)
Sales 2013 41 388 M
EBIT 2013 6 169 M
Net income 2013 3 352 M
Debt 2013 5 699 M
Yield 2013 2,44%
Sales 2014 43 615 M
EBIT 2014 6 822 M
Net income 2014 3 757 M
Debt 2014 3 728 M
Yield 2014 2,71%
PER 2013 19,18
PER 2014 16,63
EV / Sales 2013 1,82x
EV / Sales 2014 1,68x
Capitalization 69 522 M
More Financials
Latest news on BAYER AG
3d ago BAYER AG: Bayer Submits Investigational Drug Riociguat for Patients with Chroni..
4d ago BAYER AG: Bayer to acquire Steigerwald Arzneimittelwerk GmbH
4d agoDJBAYER AG: Bayer Buys Privately Held Pharmaceutical Firm in Darmstadt
4d ago BAYER AG: Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
4d ago BAYER AG: Bayer Receives U.S. FDA Approval for Cancer Treatment Xofigo® (radium..
4d ago BAYER AG: Bayer CropScience announces intention to construct a state-of-the-art..
5d ago EXCLUSIVE: Roche exploring sale of diabetes device unit
5d agoDJBAYER AG: FDA Approves New Bayer Drug for Advanced Prostate Cancer
5d ago BAYER AG: Bayer Initiates Phase III Trial of Regorafenib in Patients with Advan..
5d ago BAYER AG: Dr. Herbert Heitmann to be new Head of Communications and Government ..
6d ago BAYER AG: Bayer Head of Communications will join soccer team
05/10 Bayer's plastics chief sees room to raise prices
More news
Forum BAYER AG
Be the first to post a message on BAYER AG
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Bayer AG : Income Statement Evolution
More Financials
EPS Revisions
Bayer AG : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.